InsiderTrades.com logo

NBIX Insider Trading

Insider Ownership Percentage: 4.80%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $39,819,282.26

Neurocrine Biosciences Insider Trading History Chart

This chart shows the insider buying and selling history at Neurocrine Biosciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Neurocrine Biosciences Share Price & Price History

Current Price: $127.68
Price Change: ▼ Price Decrease of -2.02 (-1.56%)
As of 03/20/2026 05:00 PM ET

This chart shows the closing price history over time for NBIX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Neurocrine Biosciences Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/16/2026Kyle GanoCEOSell36,400$132.70$4,830,280.00140,407View SEC Filing Icon  
12/16/2025Leslie V NorwalkDirectorSell1,190$155.09$184,557.106,239View SEC Filing Icon  
12/15/2025Leslie V NorwalkDirectorSell5,000$152.23$761,150.007,429View SEC Filing Icon  
12/8/2025Darin LippoldtInsiderSell4,376$159.65$698,628.4043,405View SEC Filing Icon  
11/25/2025George J MorrowDirectorSell15,000$143.37$2,150,550.007,068View SEC Filing Icon  
11/5/2025William H. RastetterDirectorSell18,000$151.82$2,732,760.0040,360View SEC Filing Icon  
11/4/2025Kyle GanoCEOSell300$141.97$42,591.00140,407View SEC Filing Icon  
8/7/2025Kevin Charles GormanDirectorSell106,322$126.41$13,440,164.02514,596View SEC Filing Icon  
7/10/2025Ingrid DelaetInsiderSell457$135.00$61,695.004,730View SEC Filing Icon  
7/9/2025Jude OnyiaInsiderSell59,819$130.46$7,803,986.7418,289View SEC Filing Icon  
7/2/2025Jude OnyiaInsiderSell20,362$130.13$2,649,707.0618,289View SEC Filing Icon  
5/27/2025Kevin Charles GormanDirectorSell9,613$120.38$1,157,212.94514,596View SEC Filing Icon  
5/5/2025William H. RastetterDirectorSell30,000$110.20$3,306,000.0037,491View SEC Filing Icon  
2/13/2025Julie CookeInsiderSell1,551$116.78$181,125.7819,544View SEC Filing Icon  
2/13/2025Kevin Charles GormanDirectorSell5,844$116.69$681,936.36521,618View SEC Filing Icon  
2/13/2025Matt AbernethyCFOSell2,558$116.86$298,927.8834,775View SEC Filing Icon  
2/10/2025Julie CookeInsiderSell700$118.28$82,796.0018,831View SEC Filing Icon  
2/10/2025Kevin Charles GormanDirectorSell2,274$118.37$269,173.38519,074View SEC Filing Icon  
2/10/2025Kyle GanoCEOSell980$118.39$116,022.20137,658View SEC Filing Icon  
2/3/2025Ingrid DelaetInsiderSell623$149.29$93,007.673,442View SEC Filing Icon  
1/31/2025Julie CookeInsiderSell1,740$152.89$266,028.6018,202View SEC Filing Icon  
1/31/2025Kevin Charles GormanDirectorSell2,707$152.92$413,954.44517,030View SEC Filing Icon  
1/31/2025Kyle GanoCEOSell1,541$152.87$235,572.67136,778View SEC Filing Icon  
1/31/2025Matt AbernethyCFOSell1,283$152.87$196,132.2132,681View SEC Filing Icon  
1/27/2025Kevin Charles GormanDirectorSell146,105$149.46$21,836,853.30514,596View SEC Filing Icon  
1/15/2025Kyle GanoCEOSell65,000$141.50$9,197,500.00135,392View SEC Filing Icon  
12/31/2024Ingrid DelaetInsiderSell272$138.10$37,563.202,507View SEC Filing Icon  
12/17/2024Ingrid DelaetInsiderSell1,091$135.00$147,285.002,507View SEC Filing Icon  
11/29/2024Jude OnyiaInsiderSell2,331$126.29$294,381.9915,449View SEC Filing Icon  
8/15/2024William H. RastetterDirectorSell14,250$146.69$2,090,332.5037,491View SEC Filing Icon  
8/13/2024Gary A. LyonsDirectorSell11,570$150.43$1,740,475.10119,047View SEC Filing Icon  
8/13/2024Ingrid DelaetInsiderSell7,143$150.10$1,072,164.302,507View SEC Filing Icon  
8/13/2024Matt AbernethyCFOSell14,100$150.38$2,120,358.0031,528View SEC Filing Icon  
8/6/2024Ingrid DelaetInsiderSell273$147.70$40,322.106,607View SEC Filing Icon  
8/1/2024Julie CookeInsiderSell12,632$153.26$1,935,980.3218,202View SEC Filing Icon  
7/16/2024Gary A. LyonsDirectorSell930$150.03$139,527.90119,047View SEC Filing Icon  
7/16/2024Julie CookeInsiderSell900$150.04$135,036.0018,202View SEC Filing Icon  
7/1/2024Julie CookeInsiderSell10,000$140.19$1,401,900.0018,202View SEC Filing Icon  
5/29/2024Stephen A. SherwinDirectorSell40,000$133.46$5,338,400.0026,504View SEC Filing Icon  
5/17/2024Shalini SharpDirectorSell1,106$141.90$156,941.40994View SEC Filing Icon  
5/15/2024Matt AbernethyCFOSell15,000$140.24$2,103,600.0031,528View SEC Filing Icon  
5/14/2024Gary A. LyonsDirectorSell12,500$135.63$1,695,375.00116,947View SEC Filing Icon  
5/6/2024Ingrid DelaetInsiderSell273$140.55$38,370.157,507View SEC Filing Icon  
4/15/2024Eric BenevichInsiderSell19,818$133.36$2,642,928.4840,778View SEC Filing Icon  
3/21/2024Ingrid DelaetInsiderSell5,000$145.06$725,300.007,507View SEC Filing Icon  
3/14/2024Eric BenevichInsiderSell75,000$139.38$10,453,500.0040,778View SEC Filing Icon  
3/14/2024George J. MorrowDirectorSell40,000$139.42$5,576,800.00View SEC Filing Icon  
3/11/2024Ingrid DelaetInsiderSell200$140.00$28,000.007,507View SEC Filing Icon  
3/11/2024Richard F. PopsDirectorSell100$140.00$14,000.0029,512View SEC Filing Icon  
3/8/2024Ingrid DelaetInsiderSell1,800$140.03$252,054.007,507View SEC Filing Icon  
3/8/2024Richard F. PopsDirectorSell1,700$140.05$238,085.0029,512View SEC Filing Icon  
2/29/2024Ingrid DelaetInsiderSell273$135.51$36,994.237,507View SEC Filing Icon  
2/27/2024Leslie V. NorwalkDirectorSell8,000$135.67$1,085,360.00View SEC Filing Icon  
2/20/2024Richard F. PopsDirectorSell15,000$132.47$1,987,050.0029,512View SEC Filing Icon  
2/13/2024Eiry RobertsInsiderSell1,114$132.96$148,117.4423,716View SEC Filing Icon  
2/13/2024Kevin Charles GormanCEOSell2,832$133.02$376,712.64514,596View SEC Filing Icon  
2/13/2024Matt AbernethyCFOSell1,352$132.85$179,613.2031,528View SEC Filing Icon  
2/8/2024David W. BoyerInsiderSell1,328$135.41$179,824.484,895View SEC Filing Icon  
2/8/2024Kevin Charles GormanCEOSell2,274$134.15$305,057.10506,962View SEC Filing Icon  
2/8/2024Matt AbernethyCFOSell980$134.21$131,525.8030,314View SEC Filing Icon  
2/6/2024David W. BoyerInsiderSell456$141.96$64,733.764,894View SEC Filing Icon  
2/6/2024Kevin Charles GormanCEOSell3,040$142.18$432,227.20504,919View SEC Filing Icon  
2/6/2024Matt AbernethyCFOSell1,280$142.19$182,003.2029,434View SEC Filing Icon  
1/31/2024Eiry RobertsInsiderSell1,457$140.79$205,131.0320,832View SEC Filing Icon  
1/31/2024Kevin Charles GormanCEOSell2,707$140.69$380,847.83502,188View SEC Filing Icon  
1/31/2024Matt AbernethyCFOSell1,283$140.72$180,543.7628,284View SEC Filing Icon  
1/22/2024Darin LippoldtInsiderSell10,000$139.86$1,398,600.0035,882View SEC Filing Icon  
1/8/2024Kevin Charles GormanCEOSell105,835$132.44$14,016,787.40499,754View SEC Filing Icon  
1/2/2024Kyle GanoInsiderSell75,000$131.47$9,860,250.00130,250View SEC Filing Icon  
1/2/2024William H. RastetterDirectorSell11,044$131.47$1,451,954.6851,741View SEC Filing Icon  
12/22/2023Eiry RobertsInsiderSell10,000$126.74$1,267,400.0019,521View SEC Filing Icon  
12/12/2023Eiry RobertsInsiderSell13,925$120.30$1,675,177.5029,521View SEC Filing Icon  
12/8/2023Eiry RobertsInsiderSell300$120.10$36,030.0029,521View SEC Filing Icon  
12/6/2023Darin LippoldtInsiderSell20,830$119.86$2,496,683.8035,882View SEC Filing Icon  
12/1/2023Gary A. LyonsDirectorSell5,000$116.77$583,850.00203,697View SEC Filing Icon  
11/29/2023Jude OnyiaInsiderSell2,331$113.57$264,731.6711,732View SEC Filing Icon  
11/27/2023Darin LippoldtInsiderSell10,919$112.27$1,225,876.1335,882View SEC Filing Icon  
10/2/2023David W. BoyerInsiderSell1,437$112.68$161,921.164,894View SEC Filing Icon  
9/12/2023Gary A. LyonsDirectorSell5,000$115.02$575,100.00203,697View SEC Filing Icon  
9/1/2023Gary A. LyonsDirectorSell5,000$110.06$550,300.00203,697View SEC Filing Icon  
9/1/2023Julie CookeInsiderSell824$110.93$91,406.3217,263View SEC Filing Icon  
8/30/2023David W. BoyerInsiderSell2,733$107.60$294,070.803,460View SEC Filing Icon  
8/28/2023Ingrid DelaetInsiderSell1,431$107.52$153,861.125,931View SEC Filing Icon  
8/21/2023Jude OnyiaInsiderSell3,198$107.37$343,369.269,638View SEC Filing Icon  
8/21/2023Kevin Charles GormanCEOSell9,328$107.40$1,001,827.20499,754View SEC Filing Icon  
8/21/2023Matt AbernethyCFOSell2,132$107.39$228,955.4827,131View SEC Filing Icon  
5/1/2023Julie CookeInsiderSell11,397$103.89$1,184,034.3316,169View SEC Filing Icon  
5/1/2023William H. RastetterDirectorSell4,300$101.43$436,149.0042,785View SEC Filing Icon  
4/24/2023Eiry RobertsInsiderSell14,400$103.48$1,490,112.0026,644View SEC Filing Icon  
4/21/2023William H. RastetterDirectorSell6,034$105.04$633,811.3639,460View SEC Filing Icon  
4/19/2023William H. RastetterDirectorSell903$105.00$94,815.0034,729View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Neurocrine Biosciences (NASDAQ:NBIX)

92.59% of Neurocrine Biosciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at NBIX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Neurocrine Biosciences Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
3/17/2026Rockefeller Capital Management L.P.281,320$39.90M0.1%+45.0%0.280%Search for SEC Filing on Google Icon
3/9/2026Corient Private Wealth LLC5,357$0.76M0.0%+33.8%0.005%Search for SEC Filing on Google Icon
3/6/2026Hsbc Holdings PLC68,292$9.69M0.0%-62.8%0.068%Search for SEC Filing on Google Icon
3/3/2026Caitong International Asset Management Co. Ltd1,551$0.22M0.1%N/A0.002%Search for SEC Filing on Google Icon
3/2/2026Wick Capital Partners LLC1,579$0.22M0.0%N/A0.002%Search for SEC Filing on Google Icon
2/25/2026MidFirst Bank1,239$0.18M0.0%N/A0.001%Search for SEC Filing on Google Icon
2/24/2026Pacer Advisors Inc.29,621$4.20M0.0%+121.6%0.030%Search for SEC Filing on Google Icon
2/23/2026Kera Capital Partners Inc.2,188$0.30M0.0%+26.3%0.002%Search for SEC Filing on Google Icon
2/23/2026Virtu Financial LLC15,389$2.18M0.1%+775.9%0.015%Search for SEC Filing on Google Icon
2/20/2026Wick Capital Partners LLC8,054$1.14M0.1%N/A0.008%Search for SEC Filing on Google Icon
2/19/2026Invesco Ltd.343,421$48.71M0.0%+6.1%0.342%Search for SEC Filing on Google Icon
2/19/2026Corient Private Wealth LLC7,292$1.03M0.0%+82.1%0.007%Search for SEC Filing on Google Icon
2/18/2026Mercer Global Advisors Inc. ADV40,957$5.81M0.0%+29.6%0.041%Search for SEC Filing on Google Icon
2/18/2026Summit Global Investments24,804$3.52M0.2%-31.4%0.025%Search for SEC Filing on Google Icon
2/18/2026Vident Advisory LLC1,631$0.23M0.0%-11.9%0.002%Search for SEC Filing on Google Icon
2/18/2026State of Tennessee Department of Treasury33,807$4.60M0.0%-4.1%0.034%Search for SEC Filing on Google Icon
2/18/2026EP Wealth Advisors LLC2,949$0.42M0.0%N/A0.003%Search for SEC Filing on Google Icon
2/18/2026Mackenzie Financial Corp76,840$10.81M0.0%-9.5%0.077%Search for SEC Filing on Google Icon
2/18/2026NewEdge Advisors LLC12,998$1.84M0.0%+5.5%0.013%Search for SEC Filing on Google Icon
2/18/2026Empowered Funds LLC4,366$0.62M0.0%-76.8%0.004%Search for SEC Filing on Google Icon
2/18/2026XTX Topco Ltd11,775$1.67M0.0%+326.3%0.012%Search for SEC Filing on Google Icon
2/18/2026Zurich Insurance Group Ltd FI459,437$65.16M0.5%N/A0.458%Search for SEC Filing on Google Icon
2/18/2026Virtus Investment Advisers LLC4,472$0.63M0.2%+25.8%0.004%Search for SEC Filing on Google Icon
2/18/2026Wellington Management Group LLP1,744,560$247.43M0.1%-3.7%1.738%Search for SEC Filing on Google Icon
2/18/2026Toronto Dominion Bank15,883$2.25M0.0%-1.3%0.016%Search for SEC Filing on Google Icon
2/18/2026Tudor Investment Corp ET AL19,524$2.77M0.0%-27.3%0.019%Search for SEC Filing on Google Icon
2/18/2026Twinbeech Capital LP3,110$0.44M0.0%N/A0.003%Search for SEC Filing on Google Icon
2/18/2026Polymer Capital Management US LLC6,868$0.97M0.1%N/A0.007%Search for SEC Filing on Google Icon
2/18/2026Orbimed Advisors LLC314,240$44.57M0.9%-11.1%0.313%Search for SEC Filing on Google Icon
2/18/2026Oxford Asset Management LLP2,101$0.30M0.1%N/A0.002%Search for SEC Filing on Google Icon
2/18/2026Perceptive Advisors LLC331,050$46.95M0.8%-26.4%0.330%Search for SEC Filing on Google Icon
2/18/2026Millennium Management LLC442,866$62.81M0.0%-52.2%0.441%Search for SEC Filing on Google Icon
2/18/2026Man Group plc231,210$32.79M0.1%+186.0%0.230%Search for SEC Filing on Google Icon
2/18/2026Inspire Investing LLC2,340$0.33M0.0%+6.8%0.002%Search for SEC Filing on Google Icon
2/18/2026Investment Management Corp of Ontario6,659$0.94M0.0%+43.4%0.007%Search for SEC Filing on Google Icon
2/18/2026Janus Henderson Group PLC459,176$65.13M0.0%-22.8%0.458%Search for SEC Filing on Google Icon
2/18/2026Gotham Asset Management LLC168,572$23.91M0.1%+23.6%0.168%Search for SEC Filing on Google Icon
2/18/2026Element Capital Management LLC7,017$1M0.5%N/A0.007%Search for SEC Filing on Google Icon
2/18/2026Evolve Private Wealth LLC7,680$1.09M0.1%N/A0.008%Search for SEC Filing on Google Icon
2/18/2026Engineers Gate Manager LP12,320$1.75M0.0%+61.4%0.012%Search for SEC Filing on Google Icon
2/18/2026Balyasny Asset Management L.P.141,101$20.01M0.0%-30.6%0.141%Search for SEC Filing on Google Icon
2/18/2026Banco Bilbao Vizcaya Argentaria S.A.149,156$21.15M0.1%+0.9%0.149%Search for SEC Filing on Google Icon
2/18/2026Boone Capital Management LLC151,815$21.53M7.2%-8.8%0.151%Search for SEC Filing on Google Icon
2/18/2026Armistice Capital LLC820,240$116.34M1.4%+17.7%0.817%Search for SEC Filing on Google Icon
2/17/2026Freestone Grove Partners LP140,529$19.93M0.1%+6.2%0.140%Search for SEC Filing on Google Icon
2/17/2026Guggenheim Capital LLC24,043$3.41M0.0%+7.9%0.024%Search for SEC Filing on Google Icon
2/17/2026Caisse de depot et placement du Quebec62,913$8.92M0.0%N/A0.063%Search for SEC Filing on Google Icon
2/17/2026Schonfeld Strategic Advisors LLC89,972$12.76M0.1%+15.8%0.090%Search for SEC Filing on Google Icon
2/17/2026PDT Partners LLC28,781$4.08M0.3%-30.8%0.029%Search for SEC Filing on Google Icon
2/17/2026J. Goldman & Co LP53,303$7.56M0.2%+13.6%0.053%Search for SEC Filing on Google Icon
2/17/2026AQR Capital Management LLC3,271,706$462.65M0.2%+18.0%3.260%Search for SEC Filing on Google Icon
2/17/2026Braidwell LP751,534$106.59M3.4%-14.6%0.749%Search for SEC Filing on Google Icon
2/17/2026EFG International AG3,915$0.56M0.0%N/A0.004%Search for SEC Filing on Google Icon
2/17/2026Cetera Investment Advisers13,489$1.91M0.0%+2.8%0.013%Search for SEC Filing on Google Icon
2/17/2026Lazard Asset Management LLC64,925$9.21M0.0%+58.8%0.065%Search for SEC Filing on Google Icon
2/17/2026Laird Norton Wetherby Trust Company LLC3,482$0.49M0.0%N/A0.003%Search for SEC Filing on Google Icon
2/17/2026Trexquant Investment LP137,186$19.46M0.2%+332.1%0.137%Search for SEC Filing on Google Icon
2/17/2026Amundi166,350$23.59M0.0%-27.8%0.166%Search for SEC Filing on Google Icon
2/17/2026Jump Financial LLC6,824$0.97M0.0%+276.4%0.007%Search for SEC Filing on Google Icon
2/17/2026Northern Trust Corp1,221,184$173.20M0.0%+31.9%1.217%Search for SEC Filing on Google Icon
2/17/2026Vinva Investment Management Ltd74,727$10.53M0.1%+1,002.8%0.074%Search for SEC Filing on Google Icon
2/17/2026Price T Rowe Associates Inc. MD1,872,240$265.54M0.0%-34.7%1.865%Search for SEC Filing on Google Icon
2/17/2026Rock Springs Capital Management LP125,500$17.80M0.9%+39.8%0.125%Search for SEC Filing on Google Icon
2/17/2026Osaic Holdings Inc.3,177$0.45M0.0%-27.5%0.003%Search for SEC Filing on Google Icon
2/17/2026Public Employees Retirement System of Ohio31,877$4.52M0.0%-3.3%0.032%Search for SEC Filing on Google Icon
2/17/2026California State Teachers Retirement System134,172$19.03M0.0%-2.0%0.134%Search for SEC Filing on Google Icon
2/17/2026Russell Investments Group Ltd.124,803$17.69M0.0%+11.5%0.124%Search for SEC Filing on Google Icon
2/17/2026State of Wisconsin Investment Board94,527$13.41M0.0%-4.3%0.094%Search for SEC Filing on Google Icon
2/17/2026Captrust Financial Advisors30,928$4.39M0.0%+10.3%0.031%Search for SEC Filing on Google Icon
2/17/2026Fred Alger Management LLC1,985$0.28M0.0%-6.5%0.002%Search for SEC Filing on Google Icon
2/17/2026&PARTNERS1,812$0.26M0.0%+7.4%0.002%Search for SEC Filing on Google Icon
2/17/2026ExodusPoint Capital Management LP31,830$4.51M0.0%-1.9%0.032%Search for SEC Filing on Google Icon
2/17/2026Peloton Wealth Strategists13,560$1.92M0.7%-1.8%0.014%Search for SEC Filing on Google Icon
2/17/2026Royal Bank of Canada311,012$44.11M0.0%+27.1%0.310%Search for SEC Filing on Google Icon
2/17/2026Graham Capital Management L.P.1,829$0.26M0.0%-34.0%0.002%Search for SEC Filing on Google Icon
2/17/2026Magnetar Financial LLC29,192$4.14M0.0%-14.3%0.029%Search for SEC Filing on Google Icon
2/17/2026Rothschild Wealth LLC1,957$0.28M0.0%N/A0.002%Search for SEC Filing on Google Icon
2/17/2026Aster Capital Management DIFC Ltd614$87K0.0%+74.4%0.001%Search for SEC Filing on Google Icon
2/17/2026Oddo BHF Asset Management Sas7,620$1.08M0.0%+35.6%0.008%Search for SEC Filing on Google Icon
2/17/2026Rakuten Investment Management Inc.4,201$0.60M0.0%-96.7%0.004%Search for SEC Filing on Google Icon
2/17/2026Rice Hall James & Associates LLC98,020$13.90M0.8%-1.5%0.098%Search for SEC Filing on Google Icon
2/17/2026University of Texas Texas AM Investment Management Co.11,196$1.59M0.2%-26.7%0.011%Search for SEC Filing on Google Icon
2/16/2026Silvant Capital Management LLC20,273$2.88M0.1%+1.6%0.020%Search for SEC Filing on Google Icon
2/16/2026Squarepoint Ops LLC209,706$29.74M0.0%+418.0%0.209%Search for SEC Filing on Google Icon
2/16/2026Vanguard Personalized Indexing Management LLC11,238$1.59M0.0%+1.1%0.011%Search for SEC Filing on Google Icon
2/16/2026Verition Fund Management LLC28,766$4.08M0.0%-25.6%0.029%Search for SEC Filing on Google Icon
2/16/2026MML Investors Services LLC11,730$1.66M0.0%-9.9%0.012%Search for SEC Filing on Google Icon
2/16/2026Mariner LLC96,013$13.61M0.0%+75.2%0.096%Search for SEC Filing on Google Icon
2/16/2026Fieldview Capital Management LLC1,757$0.25M0.0%N/A0.002%Search for SEC Filing on Google Icon
2/16/2026Focus Partners Wealth69,934$9.92M0.0%+6.2%0.070%Search for SEC Filing on Google Icon
2/16/2026Kennedy Capital Management LLC47,051$6.67M0.1%-16.4%0.047%Search for SEC Filing on Google Icon
2/16/2026DE Burlo Group Inc.4,667$0.66M0.1%-2.1%0.005%Search for SEC Filing on Google Icon
2/16/2026Entropy Technologies LP22,523$3.19M0.2%N/A0.022%Search for SEC Filing on Google Icon
2/16/2026Arax Advisory Partners381$54K0.0%-99.1%0.000%Search for SEC Filing on Google Icon
2/16/2026Barclays PLC252,241$35.78M0.0%-17.0%0.251%Search for SEC Filing on Google Icon
2/16/2026Brown Advisory Inc.225,288$31.95M0.0%-51.9%0.224%Search for SEC Filing on Google Icon
2/16/202617 Capital Partners LLC4,335$0.62M0.3%+21.6%0.004%Search for SEC Filing on Google Icon
2/16/2026Arrowstreet Capital Limited Partnership360,711$51.16M0.0%-12.4%0.359%Search for SEC Filing on Google Icon
2/16/2026Aptus Capital Advisors LLC1,667$0.24M0.0%N/A0.002%Search for SEC Filing on Google Icon
2/13/2026Kestra Advisory Services LLC373$53K0.0%N/A0.000%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Neurocrine Biosciences logo
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, neuroendocrine, and neuropsychiatric disorders in the United States and internationally. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids. Its product candidates in clinical development include valbenazine to treat dyskinetic cerebral palsy in pediatrics and adults; NBI-921352 to treat developmental and epileptic encephalopathy syndrome in pediatrics and adults; NBI-827104 to treat epileptic encephalopathy with continuous spike-and-wave during sleep; NBI-1076986 to treat movement disorders; crinecerfront to treat congenital adrenal hyperplasia in adults and children; EFMODY to treat congenital adrenal hyperplasia and adrenal insufficiency in adults; valbenazine for the adjunctive treatment of schizophrenia; NBI-1065845 for the treatment of inadequate response to treatment in major depressive disorder; luvadaxistat to treat cognitive impairment related to schizophrenia; NBI-1117568 for the treatment of schizophrenia; NBI-1070770 to treat major depressive disorder; NBI-1117570 for the treatment of symptoms of psychosis and cognition in neurological and neuropsychiatric conditions; and NBI-1117569, NBI-1117567, and NBI-1065890 to treat CNS indications. The company also has license and collaboration agreements with Heptares Therapeutics Limited; Takeda Pharmaceutical Company Limited; Idorsia Pharmaceuticals Ltd; Xenon Pharmaceuticals Inc.; Voyager Therapeutics, Inc.; BIAL Portela & Ca, S.A.; Mitsubishi Tanabe Pharma Corporation; and AbbVie Inc. The company was incorporated in 1992 and is headquartered in San Diego, California.
Read More on Neurocrine Biosciences

Today's Range

Now: $127.68
Low: $126.68
High: $130.16

50 Day Range

MA: $132.34
Low: $123.10
High: $141.20

52 Week Range

Now: $127.68
Low: $84.23
High: $160.18

Volume

2,182,008 shs

Average Volume

967,305 shs

Market Capitalization

$12.81 billion

P/E Ratio

27.40

Dividend Yield

N/A

Beta

0.32

Who are the company insiders with the largest holdings of Neurocrine Biosciences?

Neurocrine Biosciences' top insider shareholders include:
  1. Kevin Charles Gorman (Director)
  2. Kyle Gano (CEO)
  3. Gary A Lyons (Director)
  4. Darin Lippoldt (Insider)
  5. Eric Benevich (Insider)
  6. William H Rastetter (Director)
  7. Matt Abernethy (CFO)
  8. Stephen A Sherwin (Director)
  9. Julie Cooke (Insider)
  10. Jude Onyia (Insider)
  11. Ingrid Delaet (Insider)
  12. Leslie V Norwalk (Director)
  13. George J Morrow (Director)
  14. Shalini Sharp (Director)
Learn More about top insider investors at Neurocrine Biosciences.

Who are the major institutional investors of Neurocrine Biosciences?

Neurocrine Biosciences' top institutional investors include:
  1. Vanguard Group Inc. — 9.73%
  2. Dodge & Cox — 5.52%
  3. State Street Corp — 4.26%
  4. AQR Capital Management LLC — 3.26%
  5. Renaissance Technologies LLC — 2.25%
  6. Geode Capital Management LLC — 2.07%
Learn More about top institutional investors of Neurocrine Biosciences stock.

Which institutional investors are selling Neurocrine Biosciences stock?

During the previous quarter, NBIX stock was sold by these institutional investors:
  1. Price T Rowe Associates Inc. MD
  2. Morgan Stanley
  3. Millennium Management LLC
  4. Thrivent Financial for Lutherans
  5. Macquarie Group Ltd.
  6. Brown Advisory Inc.
  7. Renaissance Technologies LLC
  8. Janus Henderson Group PLC
During the previous year, company insiders that have sold Neurocrine Biosciences company stock include:
  1. Kevin Charles Gorman (Director)
  2. Kyle Gano (CEO)
  3. Gary A Lyons (Director)
  4. Darin Lippoldt (Insider)
  5. Eric Benevich (Insider)
  6. William H Rastetter (Director)
  7. Matt Abernethy (CFO)
  8. Stephen A Sherwin (Director)
Learn More investors selling Neurocrine Biosciences stock.

Which institutional investors are buying Neurocrine Biosciences stock?

Within the previous quarter, NBIX stock was bought by institutional investors including:
  1. Norges Bank
  2. UBS Group AG
  3. AQR Capital Management LLC
  4. Zurich Insurance Group Ltd FI
  5. Northern Trust Corp
  6. Hudson Bay Capital Management LP
  7. Marshall Wace LLP
  8. Squarepoint Ops LLC